Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
CGMP Deviations
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified…
Reason Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
Reason Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Reason Presence of Foreign Substance; Broken metal piece found embedded in tablet.
Reason cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.